DKK 0.18
(-2.17%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1000.00 DKK | -36.99% |
2022 | 1587.00 DKK | 0.0% |
2021 | - DKK | 0.0% |
2020 | - DKK | -100.0% |
2019 | 71.34 Million DKK | 0.0% |
2018 | - DKK | 0.0% |
2017 | - DKK | 0.0% |
2016 | - DKK | 0.0% |
2015 | - DKK | 0.0% |
2014 | - DKK | 0.0% |
2013 | - DKK | -100.0% |
2012 | 35 Million DKK | 0.0% |
2011 | - DKK | 0.0% |
2010 | - DKK | -100.0% |
2009 | 52.71 Million DKK | 0.0% |
2008 | - DKK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - DKK | 0.0% |
2024 Q1 | - DKK | -100.0% |
2023 Q2 | 1.59 Million DKK | 0.0% |
2023 Q1 | 1.59 Million DKK | 100215.06% |
2023 Q3 | 1.59 Million DKK | 0.0% |
2023 FY | 1000.00 DKK | -36.99% |
2023 Q4 | 1000.00 DKK | -99.94% |
2022 Q2 | - DKK | 0.0% |
2022 FY | 1587.00 DKK | 0.0% |
2022 Q4 | 1587.00 DKK | 0.0% |
2021 FY | - DKK | 0.0% |
2021 Q4 | - DKK | 0.0% |
2021 Q2 | - DKK | 0.0% |
2020 Q4 | - DKK | 0.0% |
2020 FY | - DKK | -100.0% |
2020 Q2 | - DKK | 0.0% |
2019 Q4 | - DKK | 0.0% |
2019 Q2 | - DKK | 0.0% |
2019 FY | 71.34 Million DKK | 0.0% |
2018 Q4 | - DKK | 0.0% |
2018 FY | - DKK | 0.0% |
2018 Q2 | - DKK | 0.0% |
2017 Q2 | - DKK | 0.0% |
2017 FY | - DKK | 0.0% |
2017 Q4 | - DKK | 0.0% |
2016 Q2 | - DKK | 0.0% |
2016 FY | - DKK | 0.0% |
2016 Q1 | - DKK | 0.0% |
2015 Q2 | - DKK | 0.0% |
2015 Q4 | - DKK | 0.0% |
2015 Q1 | - DKK | 0.0% |
2015 FY | - DKK | 0.0% |
2015 Q3 | - DKK | 0.0% |
2014 Q4 | - DKK | 0.0% |
2014 Q3 | - DKK | 0.0% |
2014 FY | - DKK | 0.0% |
2014 Q1 | - DKK | 0.0% |
2014 Q2 | - DKK | 0.0% |
2013 Q2 | - DKK | 0.0% |
2013 FY | - DKK | -100.0% |
2013 Q3 | - DKK | 0.0% |
2013 Q4 | - DKK | 0.0% |
2013 Q1 | - DKK | -100.0% |
2012 Q3 | - DKK | 0.0% |
2012 FY | 35 Million DKK | 0.0% |
2012 Q4 | 35 Million DKK | 0.0% |
2012 Q1 | - DKK | 0.0% |
2012 Q2 | - DKK | 0.0% |
2011 Q2 | - DKK | 0.0% |
2011 FY | - DKK | 0.0% |
2011 Q3 | - DKK | 0.0% |
2011 Q4 | - DKK | 0.0% |
2011 Q1 | - DKK | 0.0% |
2010 FY | - DKK | -100.0% |
2010 Q2 | - DKK | 0.0% |
2010 Q3 | - DKK | 0.0% |
2010 Q4 | - DKK | 0.0% |
2009 FY | 52.71 Million DKK | 0.0% |
2009 Q4 | 52.71 Million DKK | 0.0% |
2008 FY | - DKK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ALK-Abelló A/S | 1.42 Billion DKK | 100.0% |
Bavarian Nordic A/S | 1.64 Billion DKK | 100.0% |
Genmab A/S | 57 Million DKK | 99.998% |
Gubra A/S | -403.98 Million DKK | 100.0% |
Novo Nordisk A/S | 31.81 Billion DKK | 100.0% |
Orphazyme A/S | -1099.00 DKK | 190.992% |
Zealand Pharma A/S | 7.93 Million DKK | 99.987% |